ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Temporal Pattern of Radiological Resolution in Chronic Subdural Hematoma After Middle Meningeal Artery Embolization: A Prospective 2-Center Study.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Middle meningeal artery embolization (MMAE) treats chronic subdural hematoma (cSDH) by devascularizing the hematoma membrane, but the timing of radiological resolution remains incompletely defined. This prospective 2-center study evaluated computed tomography (CT) outcomes at 1 and 3 months after MMAE in Vietnam. MATERIAL AND METHODS Consecutive patients treated from November 2021 through December 2024 were enrolled. Maximum hematoma thickness and midline shift were measured on baseline imaging and follow-up non-contrast-enhanced CT. Paired measurements were compared using paired t tests. Analyses were performed at the hematoma level using available paired observations. RESULTS The cohort included 67 patients with 90 cSDHs. Follow-up CT was available for 76 hematomas at 1 month and 40 at 3 months. Mean hematoma thickness decreased from 14.2±5.3 mm at baseline to 8.7±10.2 mm at 1 month and 3.5±5.6 mm at 3 months (both P<0.001). Mean midline shift decreased from 6.1±4.3 mm to 0.81±1.54 mm and 0.69±1.93 mm, respectively (both P<0.001). Complete resolution was observed in 12 of 76 hematomas (15.8%) at 1 month and 23 of 40 (57.5%) at 3 months. CONCLUSIONS MMAE was associated with a gradual reduction in hematoma thickness and midline shift among hematomas with available follow-up imaging. These findings suggest that residual hematoma on early post-treatment imaging may not necessarily indicate treatment failure. However, the delayed radiological trajectory should be interpreted cautiously because 3-month imaging follow-up was incomplete and may be affected by attrition bias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.